SCHEMBL23744790

SCHEMBL23744790

O=C(OC1CC2(C1)CN(Cc1ccccc1)C2)N1CCN(c2ncc(OCC3CCC3)cn2)CC1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.41
CHRM1 P11229 1/20 0.41
CHRM4 P08173 3/20 0.41
ALDH1A1 P00352 3/20 0.40
CYP3A4 P08684 3/20 0.40
CYP2D6 P10635 3/20 0.40
TSHR P16473 1/20 0.40
F2 P00734 1/20 0.40
PRSS1 P07477 1/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
USP2 O75604 1/20 0.40
HTR7 P34969 1/20 0.39
GPR119 Q8TDV5 2/20 0.39
ACACB O00763 1/20 0.39
OPRD1 P41143 1/20 0.38
OPRK1 P41145 1/20 0.38
ACHE P22303 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24945665 0.88 MAPK1 (0.45) CHRM2CHRM1CHRM4ALDH1A1CYP3A4
SCHEMBL24945637 0.87 CYP3A4 (0.41) CHRM2CHRM1CHRM4ALDH1A1CYP3A4
SCHEMBL26429953 0.87 CHRM2 (0.45) CHRM2CHRM1CHRM4ACACB
SCHEMBL24945761 0.86 HTR7 (0.44) CHRM2CHRM1CHRM4ALDH1A1CYP3A4
SCHEMBL23744120 0.85 CYP2D6 (0.45) CHRM2CHRM1CHRM4ALDH1A1CYP3A4
SCHEMBL26089375 0.84 CYP3A4 (0.46) CHRM2CHRM1CHRM4ALDH1A1CYP3A4
SCHEMBL23744809 0.83 CYP2D6 (0.42) CHRM2CHRM1CHRM4ALDH1A1CYP3A4
SCHEMBL26429791 0.83 CHRM2 (0.46) CHRM2CHRM1CHRM4
SCHEMBL26087084 0.82 CHRM2 (0.56) CHRM2CHRM1CHRM4CYP3A4CYP2D6
SCHEMBL24944794 0.81 ALDH1A1 (0.40) CHRM2CHRM1CHRM4ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021158698-A1 MUSCARINIC RECEPTOR 4 ANTAGONISTS AND METHODS OF USE NEUROCRINE BIOSCIENCES, INC. (US) 2021-08-12 WO disclosed